Register for our free email digests:
Abbott Laboratories Inc.
www.abbott.com
Latest From Abbott Laboratories Inc.
ACC Results Recap Part II: CardioMEMS Post-Approval Trial Shows Monitoring Reduces Heart-Failure Hospitalizations; Medtronic’s Tyrx Envelope Reduces Infections
Medtech Insight's Results Recap is a regular feature covering the major device trial results compiled by MedDeviceTracker. This is the second of three Results Recaps covering trial data presented at the American College of Cardiology Scientific Sessions in New Orleans, March 16-18, including clinical trial data on devices from Abbott Laboratories, Medtronic, Medi-Lynx, and iRhythm. See Part 1 of our ACC Results Recap for more on the groundbreaking trials of transcatheter aortic valve replacement in low-risk patients and the Apple Heart study of Apple Watch's ability to track atrial fibrillation.
Asia Deal Watch: Zogenix Partners Japanese Rights To Pediatric Epilepsy Therapy To Nippon Shinyaku
Nippon Shinyaku obtains rights to sell Dravet and Lennox-Gastaut syndrome drug Fintepla in its home market. Sun Pharma increases its ownership stake in Russia’s PJSC Biosintez.
Abbott Builds Its Digital Reach In India
Abbott’s new digital initiative in India, which already has 2,000 physicians and 1,000 patients on board, aims to provide services and information to improve health outcomes. Gamification concepts and an offline component such as a learning program for physicians are also part of the new offering.
Global Device Approvals, Weekly Snapshot: FDA Approves Bard’s Venovo Stent; Abbott’s MitraClip Gets Indication-Expansion; Boston Scientific’s Watchman FLX Earns CE Mark
A snapshot of global medical device approvals captured during the past week in Medtech Insight's Approvals Tracker. This week, FDA approved Bard’s Venovo venous stent system for symptomatic iliofemoral venous outflow obstruction, FDA added functional mitral regurgitation to the approved labeling for Abbott’s market-leading MitraClip, and Watchman FLX, Boston Scientific’s next-generation left-atrial appendage closer earned a CE Mark in Europe.
Company Information
- Industry
-
In Vitro Diagnostics
- Chemistry, Immunoassay
-
Medical Devices
- Implantable Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
-
Pharmaceuticals
- Generic Drugs
- Therapeutic Areas
- Cardiovascular
- Gastrointestinal
- Infectious & Viral Diseases
- Metabolic Disorders
- Musculoskeletal & Connective Tissue Disorders
- Neurology, Nervous System
- Alias(es)
- Ownership
- Public
- Headquarters
-
Worldwide
-
North America
-
USA
-
USA
-
North America
- Company Type
- Big Pharma
- Parent & Subsidiaries
-
Abbott Laboratories Inc.
- Abbott Bioresearch Center
- Abbott Biotech Inc.
- Abbott Canada Ltd.
- Abbott Diabetes Care Inc.
- Abbott Diagnostics
- Abbott GMBH & Co. KG
- Abbott International
- Abbott Japan Co. Ltd.
- Abbott Molecular Inc.
- Abbott Nutrition
- Abbott Point of Care
- Abbott Vascular
- Advanced Cardiovascular Systems Inc.
- Alcyon Analyzer SA
-
Alere Inc.
- AdnaGen AG
- Alere Medical Inc.
- Alere Toxicology
- Applied Biotech Inc.
- Arriva Medical LLC
- Axis-Shield PLC
- BBI Holdings PLC
- Binax Inc.
- Biosite Inc.
- Cholestech Corp.
- Diamics Inc.
- eScreen Inc.
- First Check Diagnostics LLC
- HemoSense Inc.
- Instant Technologies Inc.
- Inverness Medical Deutschland GMBH
- Ischemia Technologies Inc.
- Matria Healthcare Inc.
- MZT Holdings Inc.
- Ostex International Inc.
- Redwood Toxicology Laboratory Inc.
- Standard Diagnostics Inc.
- Swiss Precision Diagnostics GMBH
- Thermo BioStar Inc.
- Unipath Ltd.
- US Diagnostics Inc.
- Wampole Laboratories
- Bioabsorbable Vascular Solutions
- Boots Pharmaceuticals Inc.
- CFR Pharmaceuticals SA
- EndoVascular Technologies Inc.
- Evalve Inc.
- Facet Biotech Corp.
- Hokuriku Seiyaku Co. Ltd.
- Ibis Biosciences Inc.
- IDev Technologies Inc.
- Integrated Vascular Systems Inc.
- International Murex Technologies Corp.
- Kalila Medical
- Knoll Pharmaceutical Co.
- Knoll Pharmaceuticals Canada
- Kos Pharmaceuticals Inc.
- Murex Diagnostics Inc.
- Perclose Inc.
- Puleva Union Industrial y Agroganadera SA
- Ravizza Farmaceutici S.p.A.
- Ross Laboratories
- Ross Products
- Solvay Pharmaceuticals SA
- Spine Next SA
-
St. Jude Medical Inc.
- Advanced Neuromodulation Systems Inc.
- AGA Medical Holdings Inc.
- Aries Medical Inc.
- CardioMEMS Inc.
- Daig Corp.
- Endocardial Solutions Inc.
- Endosense SA
- EP MedSystems Inc.
- Epicor Medical Inc.
- Getz Bros. & Co. Ltd.
- Irvine Biomedical Inc.
- LightLab Imaging Inc.
- MediGuide Ltd.
- Nanostim Inc.
- NeuroTherm Inc.
- Northstar Neuroscience Inc.
- Pacesetter Inc.
- Radi Medical Systems
- Savacor Inc.
- Spinal Modulation Inc.
- St. Jude Medical Division
- St. Jude Medical Ltd.
- Telectronics Holdings Ltd.
- Telectronics Pacing Systems Inc.
- Thoratec Corp.
- Vascular Science Inc.
- Velocimed Inc.
- Ventritex Inc.
- Tendyne Holdings Inc.
- TheraSense Inc.
- Topera Medical Inc.
- TTP Corp.
- Veropharm
- Vysis Inc.
- X Technologies Inc.
- Senior Management
-
Miles D White, Chmn. & CEO
Brian B Yoor, EVP, Fin. & CFO
Elaine R Leavenworth, SVP, Chief Mktg. & External Affairs Officer
Robert Ford, Pres., COO & EVP, Med. Devices - Contact Info
-
Abbott Laboratories Inc.
Phone: (847) 937-6100
100 Abbott Park Rd.
Abbott Park, IL 60064-3500
USA
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice